Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Katalin Karikó named the 2022 recipient of the Pearl Meister Greengard Prize

Katalin Karikó discovered how to keep synthetic RNA from activating the innate immune system, paving the way for RNA vaccines including two for SARS-CoV-2.

>

Novel method for trapping HIV inside its host may give rise to new antivirals

Human cells can be coaxed into preventing certain enveloped viruses (including HIV, Ebola, and parainfluenza) from escaping their membranes in the lab, a finding that could lead to novel treatments for many viral diseases.

Linker histones tune the length and shape of chromosomes

A new study finds that proteins known as linker histones control the complex coiling process that determines whether DNA will wind into long and thin chromosomes, made up of many small loops, or short and thick chromosomes with fewer large loops.

Hospital hallway installation honors 11 women scientists at Rockefeller

Uncovering the chemical composition of histones and innovating addiction treatment are only two of the accomplishments of the women scientists featured in a new photographic display.

A refurbished pharmacy supports research trials at Rockefeller

A new pharmacy with clean room and other features makes it possible for pharmacists to prepare highly specialized compounds and sterile injectable drugs for use in clinical research.

Three Rockefeller researchers are named HHMI investigators

Daniel Kronauer, who studies evolution in insect societies, Daniel Mucida, who examines mucosal immunology, and Vanessa Ruta, who investigates neural circuits that underlie innate and learned behaviors, are among 33 scientists nationwide to receive this designation.

Rockefeller leads global university ranking in measure of top cited publications

An international ranking of research institutions by U-Multirank placed Rockefeller first in a measure of its impact based on citations.

Rockefeller postdoc, Luka Mesin, named a Blavatnik Regional Award Finalist

Mesin, a member of the Victora Lab, receives the honor for developing novel techniques to better understand how B cells in the immune system mature and evolve to create antibodies to fight off pathogens.

Could future coronavirus variants fully dodge our immune system?

Studying dozens of naturally occurring and laboratory-selected mutations in SARS-CoV-2, researchers found that the virus will need to pull off a genetic feat to become fully resistant to antibodies.

Rockefeller faculty member, Leslie B. Vosshall, named vice president and chief scientific officer of the Howard Hughes Medical Institute

Vosshall will join the leadership team at HHMI, a major philanthropy that supports basic biomedical scientists and educators.